Rocco Venezia
Comptroller/Controller/Auditor at INTERCEPT PHARMACEUTICALS, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Jerome B. Durso | M | 56 | 7 years | |
Michael Gemellaro | M | 50 |
Intercept Pharma Deutschland GmbH
Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015.
Intercept Pharma UK & Ireland Ltd.
Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | - |
Willem Wouter Van Weperen | M | 57 |
Intercept Pharma UK & Ireland Ltd.
Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK.
Intercept Pharma Deutschland GmbH
Intercept Pharma Deutschland GmbH Medical DistributorsDistribution Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma Deutschland GmbH is a German company focused on building a healthier tomorrow for patients with progressive non-viral liver diseases. The company is based in Munich, Germany. The CEOs are Rocco Venezia, Michael Gemellaro, Willem Wouter Van Weperen. The company was founded in 2015. | - |
Jared M. Freedberg | M | 55 | 3 years | |
Giancarlo Notarianni | M | 51 |
Intercept Pharma Ltd.
Intercept Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2016, Intercept Pharma Ltd. is a British company that engages in the development and commercialization of novel therapeutics. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK.
Intercept Pharma UK & Ireland Ltd.
Intercept Pharma UK & Ireland Ltd. Medical DistributorsDistribution Services Founded in 2015, Intercept Pharma UK & Ireland Ltd. is a pharmaceutical wholesaler. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | - |
Stefano Pasi | M | - | 1 years | |
Jose Truzman | M | - | - | |
Caroline Amelia Stockwell | F | - |
Intercept Pharma Spain SLU
Intercept Pharma Spain SLU Pharmaceuticals: MajorHealth Technology Founded in 2015, Intercept Pharma Spain SLU is a Spanish pharmaceutical company that manufactures pharmaceutical products. Part of Intercept Pharmaceuticals, Inc., the company is based in Madrid, Spain. | 3 years |
Francisco Javier Barcelo Sanchez | M | - |
Intercept Pharma Spain SLU
Intercept Pharma Spain SLU Pharmaceuticals: MajorHealth Technology Founded in 2015, Intercept Pharma Spain SLU is a Spanish pharmaceutical company that manufactures pharmaceutical products. Part of Intercept Pharmaceuticals, Inc., the company is based in Madrid, Spain. | 9 years |
Shanatilal Kapadiasandipkumar | M | - |
Intercept Pharma Spain SLU
Intercept Pharma Spain SLU Pharmaceuticals: MajorHealth Technology Founded in 2015, Intercept Pharma Spain SLU is a Spanish pharmaceutical company that manufactures pharmaceutical products. Part of Intercept Pharmaceuticals, Inc., the company is based in Madrid, Spain. | 6 years |
M. Berrey | M | 57 | 3 years | |
Graham Charles Higson | M | 68 |
Intercept Pharma Ltd.
Intercept Pharma Ltd. Miscellaneous Commercial ServicesCommercial Services Founded in 2016, Intercept Pharma Ltd. is a British company that engages in the development and commercialization of novel therapeutics. Part of Intercept Pharmaceuticals, Inc., the company is based in Bristol, UK. | 8 years |
Linda M. Richardson | F | 60 | 6 years | |
Patrick Charre | M | - |
Intercept Pharma France SAS
Intercept Pharma France SAS Miscellaneous Commercial ServicesCommercial Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma France SAS is a French company that engages in the development and commercialization of novel therapeutics. The company is based in Paris, France. The company was founded in 2015. Patrick Charre has been the CEO of the company since 2017. | 7 years |
Francisco Barcelo Sanchez | M | - |
Intercept Pharma France SAS
Intercept Pharma France SAS Miscellaneous Commercial ServicesCommercial Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma France SAS is a French company that engages in the development and commercialization of novel therapeutics. The company is based in Paris, France. The company was founded in 2015. Patrick Charre has been the CEO of the company since 2017. | 3 years |
Francesco Balestrieri | M | 55 | 1 years | |
Andrew Saik | M | 54 | 3 years | |
Michele Cera | F | - | 1 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Mark Pruzanski | M | 56 | 21 years | |
Barbara Duncan | F | 59 | 7 years | |
Bryan Ball | M | 54 | 5 years | |
Paolo Fundarò | M | 50 | 17 years | |
Daniel Tassé | M | 64 | 7 years | |
Jonathan Silverstein | M | 57 | 7 years | |
Srini Akkaraju Akkaraju | M | 56 | 11 years | |
Nancy Miller-Rich | F | 65 | 5 years | |
Dagmar Rosa-Bjorkeson | F | 60 | 2 years | |
Sandipkumar S. Kapadia | M | 54 | 5 years | |
Mark Vignola | M | 47 | 4 years | |
Keith Gottesdiener | M | 70 | 7 years | |
Bryan Yoon | M | 46 | 4 years | |
Ryan Sullivan | M | 48 | 2 years | |
Luca Benatti | M | 63 | 9 years | |
Daniel Welch | M | 66 | 6 years | |
Glenn Sblendorio | M | 68 | 9 years | |
Daniel Bradbury | M | 62 | 7 years | |
Klaus Veitinger | M | 62 | 4 years | |
Gino Santini | M | 66 | 8 years | |
David Ford | M | 56 | 6 years | |
Thomas Englese | M | 50 | 7 years | |
Melissa Rewolinski | M | 54 | 10 years | |
Caileigh Dougherty | F | - | - | |
Joseph Vazzano | M | 40 | 1 years | |
Senthil Sundaram | M | 46 | 4 years | |
Christopher Frates | M | - | - | |
Emmanuelle Nuris-Souquet | F | - |
Intercept Pharma France SAS
Intercept Pharma France SAS Miscellaneous Commercial ServicesCommercial Services Part of Intercept Pharmaceuticals, Inc., Intercept Pharma France SAS is a French company that engages in the development and commercialization of novel therapeutics. The company is based in Paris, France. The company was founded in 2015. Patrick Charre has been the CEO of the company since 2017. | 2 years |
Ingrid Delaet | M | 58 | 5 years | |
Richard Kim | M | 54 | 6 years | |
Joseph Stauffer | M | 58 | 2 years | |
Peter Fernandes | M | 69 | 3 years | |
Gail Cawkwell | M | 62 | - | |
Lisa Bright | F | 56 | 7 years | |
Jason A. Campagna | M | 54 | 2 years | |
Lisa M. DeFrancesco | F | 45 | 3 years | |
Matthew Bennett | M | 52 | 8 years | |
Elizabeth Betten | F | 43 | 1 years | |
Christian Weyer | M | 55 | - | |
Anastasios Konidaris | M | 57 | 8 years | |
Jason Shideler | M | - | 1 years | |
David Shapiro | M | 69 | 12 years | |
Timothy Sullivan | M | 66 | 1 years | |
Rachel McMinn | M | 51 | 3 years | |
Martin D. Meglasson | M | 74 | 4 years | |
Lota Zoth | F | 64 | 7 years | |
Leah Neufeld | F | - | 4 years |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 55 | 84.62% |
United Kingdom | 4 | 6.15% |
Spain | 3 | 4.62% |
France | 3 | 4.62% |
Germany | 2 | 3.08% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Rocco Venezia
- Personal Network